These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11960694)

  • 21. The role of the p53 molecule in cancer therapies with radiation and/or hyperthermia.
    Ohnishi T
    J Cancer Res Ther; 2005; 1(3):147-50. PubMed ID: 17998646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.
    Farnebo M; Bykov VJ; Wiman KG
    Biochem Biophys Res Commun; 2010 May; 396(1):85-9. PubMed ID: 20494116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.
    Yoshida K; Miki Y
    Cancer Sci; 2010 Apr; 101(4):831-5. PubMed ID: 20132225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of wild-type p53 function in human cancer: relevance for tumor therapy.
    Bossi G; Sacchi A
    Head Neck; 2007 Mar; 29(3):272-84. PubMed ID: 17230559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hitting cancers' weak spots: vulnerabilities imposed by p53 mutation.
    Gurpinar E; Vousden KH
    Trends Cell Biol; 2015 Aug; 25(8):486-95. PubMed ID: 25960041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Stat3 in regulating p53 expression and function.
    Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
    Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.
    Chen X; Ko LJ; Jayaraman L; Prives C
    Genes Dev; 1996 Oct; 10(19):2438-51. PubMed ID: 8843196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line.
    Rosenfeld MR; Meneses P; Dalmau J; Drobnjak M; Cordon-Cardo C; Kaplitt MG
    Neurology; 1995 Aug; 45(8):1533-9. PubMed ID: 7644054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?
    Levesque AA; Eastman A
    Carcinogenesis; 2007 Jan; 28(1):13-20. PubMed ID: 17088261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
    Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for p53-based cancer therapy.
    Stokłosa T; Gołab J
    Acta Biochim Pol; 2005; 52(2):321-8. PubMed ID: 15990917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.
    Gomez-Manzano C; Fueyo J; Kyritsis AP; McDonnell TJ; Steck PA; Levin VA; Yung WK
    J Natl Cancer Inst; 1997 Jul; 89(14):1036-44. PubMed ID: 9230885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional regulation by mutant p53 and oncogenesis.
    Santoro R; Strano S; Blandino G
    Subcell Biochem; 2014; 85():91-103. PubMed ID: 25201190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.
    Alli E; Yang JM; Hait WN
    Oncogene; 2007 Feb; 26(7):1003-12. PubMed ID: 16909102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
    Garufi A; Pistritto G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells.
    Tanigawa S; Fujii M; Hou DX
    Biosci Biotechnol Biochem; 2008 Mar; 72(3):797-804. PubMed ID: 18323654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.